• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[通过阿托品酯(SCH 1000)对心动过缓进行长期治疗。电生理及临床结果]

[Long-term treatment of bradycardia by means of an atropine ester (SCH 1000). Electrophysiological and clinical results].

作者信息

Trieb G, Mertens H M, Bistreanu I, Mannebach H, Gleichmann U

出版信息

Z Kardiol. 1979 Oct;68(10):700-4.

PMID:160146
Abstract

Electrophysiological effects of the atropin ester Ipatropiumbromide (SCH 1000) were investigated in 15 patients by His electrocardiography and high frequency atrial stimulation. Heart rate increased by 50% of base line heart rate, PA- and AH-intervals and sinus node recovery time decreased, the HF-interval remained unchanged. Physiological av-block by atrial stimulation occurred at significant higher stimulation frequencies with SCH 1000 than without medication. Additional 15 patients were treated for a longer follow-up period. Increase of resting heart rate averaged 15%. Equivocal effects on heart rate were found with exercise after SCH 1000. Non-cardiac side effects were found in 5 patients.

摘要

通过希氏束心电图和高频心房刺激,对15例患者研究了阿托品酯异丙托溴铵(SCH 1000)的电生理效应。心率增加至基线心率的50%,PA间期和AH间期以及窦房结恢复时间缩短,HF间期保持不变。与未用药时相比,使用SCH 1000时,通过心房刺激产生生理性房室传导阻滞所需的刺激频率显著更高。另外15例患者接受了更长时间的随访治疗。静息心率平均增加15%。使用SCH 1000后运动时,对心率的影响不明确。5例患者出现非心脏副作用。

相似文献

1
[Long-term treatment of bradycardia by means of an atropine ester (SCH 1000). Electrophysiological and clinical results].[通过阿托品酯(SCH 1000)对心动过缓进行长期治疗。电生理及临床结果]
Z Kardiol. 1979 Oct;68(10):700-4.
2
[Comparative study of the efficacy and action duration of ipratropium bromide and atropine sulfate using His bundle-EG and tracing ECG in bradycardial arrhythmias].
Verh Dtsch Ges Inn Med. 1977;83:333-6.
3
[Heart rate behaviour and hemodynamics after oral therapy with ipratropium bromide in patients with sinus bradycardia (author's transl)].异丙托溴铵口服治疗窦性心动过缓患者后的心率行为和血流动力学(作者译)
Arzneimittelforschung. 1981;31(10):1751-4.
4
[The effect of ouabain on sinus node function and intracardiac conduction (author's transl)].哇巴因对窦房结功能及心内传导的影响(作者译)
Z Kardiol. 1977 May;66(5):223-30.
5
[Action of an atropine derivative, Ipratropiumbromide (SCH 1000) in bradycardia].[阿托品衍生物异丙托溴铵(SCH 1000)对心动过缓的作用]
Med Welt. 1979 Feb 23;30(8):292-7.
6
[The effect of Ro 11-1781, a calciumantagonist, on atrioventricular conduction (author's transl)].钙拮抗剂Ro 11 - 1781对房室传导的影响(作者译)
Z Kardiol. 1977 May;66(5):238-41.
7
[Treatment of bradycardia with an atropine ester].[用阿托品酯治疗心动过缓]
Z Kardiol. 1975 Apr;64(4):329-37.
8
[The electrophysiologic constellation of the so-called "sick sinus syndrome" (author's transl)].[所谓“病态窦房结综合征”的电生理情况(作者译)]
Z Kardiol. 1977 Jun;66(6):303-9.
9
[Electrophysiological effects of the antiarrhythmia agents disopyramide and propafenone on human heart conduction system].抗心律失常药物双异丙吡胺和普罗帕酮对人体心脏传导系统的电生理效应
Z Kardiol. 1975 Aug;64(8):731-40.
10
[Clinical, electrocardiographic and electrophysiologic evaluation of intravenous and oral ipratropium bromide in patients with symptomatic bradycardia].[静脉及口服异丙托溴铵对有症状心动过缓患者的临床、心电图及电生理评估]
Pol Tyg Lek. 1993;48(14-15):324-6.